Trials / Completed
CompletedNCT00986349
Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study
A Phase II Single-Center, Prospective, Open Label Efficacy Study, of the GI EndoBarrier™ Liner for the Treatment of Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Morphic Medical Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to demonstrate the safety and efficacy of the Gastrointestinal (GI) EndoBarrier in the glycemic control of diabetes in subjects with Type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EndoBarrier Liner | 52 week treatment of EnoBarrier Liner |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-11-01
- Completion
- 2012-11-01
- First posted
- 2009-09-29
- Last updated
- 2017-02-17
- Results posted
- 2017-01-02
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00986349. Inclusion in this directory is not an endorsement.